Literature DB >> 8577796

Mood and performance effects of caffeine in relation to acute and chronic caffeine deprivation.

N J Richardson1, P J Rogers, N A Elliman, R J O'Dell.   

Abstract

The mood and performance effects of caffeine deprivation (either 90 min, overnight, or at least 7 days) and ingestion (70 and 250 mg) were compared in young adults who were normally either moderate consumers (n = 49) or nonconsumers of caffeine (n = 18). Overnight caffeine deprivation produced dysphoric symptoms characteristic of caffeine withdrawal that were reduced, but still present, after longer-term abstinence. Acute caffeine intake affected the withdrawn consumers, nonwithdrawn consumers, and nonconsumers similarly. It increased jitteriness and decrease tiredness and headache. Furthermore, hand steadiness decreased as caffeine dose increased, whereas 70 mg, but not 250 mg, of caffeine was found to enhance performance on a simple reaction time task. These findings support the view that the negative effects experienced after overnight and longer-term caffeine deprivation play a significant role in influencing consumption of caffeine-containing drinks. Therefore, it would appear that to avoid the dysphoric symptoms resulting from both under- and overconsumption, regular caffeine consumers would have to regulate their caffeine intake fairly precisely.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8577796     DOI: 10.1016/0091-3057(95)00029-v

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  21 in total

Review 1.  A critical review of caffeine withdrawal: empirical validation of symptoms and signs, incidence, severity, and associated features.

Authors:  Laura M Juliano; Roland R Griffiths
Journal:  Psychopharmacology (Berl)       Date:  2004-09-21       Impact factor: 4.530

2.  Effects of caffeine on performance and mood: withdrawal reversal is the most plausible explanation.

Authors:  Jack E James; Peter J Rogers
Journal:  Psychopharmacology (Berl)       Date:  2005-07-02       Impact factor: 4.530

3.  Attentional bias for caffeine-related stimuli in high but not moderate or non-caffeine consumers.

Authors:  Martin R Yeomans; Shabnam Javaherian; Heather M Tovey; Lorenzo D Stafford
Journal:  Psychopharmacology (Berl)       Date:  2005-10-12       Impact factor: 4.530

4.  Differential responsiveness to caffeine and perceived effects of caffeine in moderate and high regular caffeine consumers.

Authors:  A S Attwood; S Higgs; P Terry
Journal:  Psychopharmacology (Berl)       Date:  2006-11-29       Impact factor: 4.530

5.  Influence of caffeine on the liking of novel-flavored soda in adolescents.

Authors:  Jennifer L Temple; Amanda M Ziegler; Adam Graczyk; Ashley Bendlin; Shannon O'Leary; Yasemin S Schnittker
Journal:  Psychopharmacology (Berl)       Date:  2012-03-20       Impact factor: 4.530

6.  Drug testing in children with excessive daytime sleepiness during multiple sleep latency testing.

Authors:  Eliot S Katz; Kiran Maski; Amanda J Jenkins
Journal:  J Clin Sleep Med       Date:  2014-08-15       Impact factor: 4.062

7.  Naturalistic Effects of Five Days of Bedtime Caffeine Use on Sleep, Next-Day Cognitive Performance, and Mood.

Authors:  Emma K Keenan; Brian Tiplady; Caroline M Priestley; Peter J Rogers
Journal:  J Caffeine Res       Date:  2014-03-01

8.  A comparison of the effects of caffeine following abstinence and normal caffeine use.

Authors:  Merideth A Addicott; Paul J Laurienti
Journal:  Psychopharmacology (Berl)       Date:  2009-09-24       Impact factor: 4.530

9.  Cardiovascular responses to caffeine by gender and pubertal stage.

Authors:  Jennifer L Temple; Amanda M Ziegler; Adam Graczyk; Ashley Bendlin; Teresa Sion; Karina Vattana
Journal:  Pediatrics       Date:  2014-06-16       Impact factor: 7.124

Review 10.  Caffeine as an attention enhancer: reviewing existing assumptions.

Authors:  Suzanne J L Einöther; Timo Giesbrecht
Journal:  Psychopharmacology (Berl)       Date:  2012-12-16       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.